Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Work In Process: 2022-2024

Historic Work In Process for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $584,000.

  • Arcutis Biotherapeutics' Work In Process rose 165.15% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year increase of 165.15%. This contributed to the annual value of $584,000 for FY2024, which is 20.16% up from last year.
  • According to the latest figures from FY2024, Arcutis Biotherapeutics' Work In Process is $584,000, which was up 20.16% from $486,000 recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Work In Process registered a high of $584,000 during FY2024, and its lowest value of $395,000 during FY2022.
  • Moreover, its 3-year median value for Work In Process was $486,000 (2023), whereas its average is $488,333.
  • Data for Arcutis Biotherapeutics' Work In Process shows a peak YoY increased of 23.04% (in 2023) over the last 5 years.
  • Over the past 3 years, Arcutis Biotherapeutics' Work In Process (Yearly) stood at $395,000 in 2022, then rose by 23.04% to $486,000 in 2023, then grew by 20.16% to $584,000 in 2024.